FDA Email Surveillance Generates Court Battle And Image Problem
This article was originally published in The Tan Sheet
FDA’s biggest battle could be in the court of public opinion as employees claim the agency targeted and suppressed them based on their viewpoints and conducted intrusive searches and seizures. FDA says the surveillance began after a device industry attorney complained that a firm’s confidential information had been released.
You may also be interested in...
Six current and former employees of FDA’s device center file suit in the U.S. District Court in Washington, D.C., arguing that email and computer surveillance violated their constitutional and legal whistleblower rights.
Federal officials took steps last week to reinstate a recently fired reviewer in FDA's diagnostics office, claiming that agency actions may have violated the Whistleblower Protection Act.
Details trickling into the public sphere about CDRH's device review process reveal heightened tension between reviewers and management over the proper response to a 510(k) submission